Elixiron Immunotherapeutics

Elixiron closes $27M series A for Alzheimer's and vitiligo clinical trials
Fierce Biotech
Mon, 08/23/21 - 11:18 pm
Elixiron Immunotherapeutics
funding
Alzheimer's disease
immuno-oncology